TheEdgeResearch
Home / Stocks / FIORF

Fiore Cannabis Ltd. (FIORF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$1,971
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.88
52-Wk Range
0.000001-0.00002
CEO
Erik Anderson
Country
CA
Currency
USD

Fiore Cannabis Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Kelowna, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,971. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -280.9%. Its beta of 0.88 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.01
EV / EBITDA
-2.71
Gross margin
22.6%
Operating margin
-181.9%
Net margin
-280.9%
Return on equity
—
Debt / equity
-39.85
Current ratio
0.25
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2015-09-01
Headquarters
Kelowna, BC, CA
About Fiore Cannabis Ltd.

Fiore Cannabis Ltd. is engaged in the cultivation, manufacturing, and distribution of cannabis products for both medical and adult-use purposes throughout the United States. The company also oversees a retail dispensary situated in California. Established in 2007, this entity previously operated under the name Citation Growth Corp. before rebranding as Fiore Cannabis Ltd. in October 2020. Its corporate headquarters are located in Kelowna, Canada.

Comparable companies

Fiore Cannabis Ltd. is most often compared with the following Healthcare names:

CBGIHCANFLOWLFMDITMDXLMPXOFMRRCFNUGSPTLFUSMJ
More research on FIORF
FIORF technical analysis FIORF TheEdge Score Compare against peers
Open full interactive analysis & DCF →